Cefepime

Common Uses

Cefepime is a cephalosporin antibiotic prescribed to treat moderate to severe infections caused by susceptible bacteria. It works by stopping the growth of bacteria or killing them directly. It is commonly used for the following conditions:

• Pneumonia: Treating moderate to severe lung infections.
• Urinary Tract Infections (UTIs): Managing both simple and complicated infections of the urinary system, including kidney infections (pyelonephritis).
• Skin Infections: Treating infections of the skin and the underlying tissues.
• Intra-abdominal Infections: Used to treat infections within the abdominal cavity, typically in combination with other antibiotics like metronidazole.
• Febrile Neutropenia: Providing initial treatment for patients who have a fever and a very low white blood cell count, which makes them highly susceptible to severe infection.

This medication is administered by injection into a vein (intravenously) or a large muscle (intramuscularly). It is important to note that cefepime only treats bacterial infections. It is not effective against viral infections, such as the common cold or the flu.

Mechanism of Action

Cefepime belongs to a class of medications known as cephalosporin antibiotics. It works by targeting and killing the bacteria responsible for an infection.

Bacteria require a sturdy outer layer called a cell wall to maintain their structure and survive in the body. Cefepime works by binding to and inhibiting specific proteins that bacteria use to build and repair these walls. When these proteins are blocked, the bacteria cannot complete the construction of their cell walls.

As the cell wall weakens, it can no longer withstand the internal pressure of the bacterial cell. This causes the bacteria to burst and die. This process helps the body's immune system eliminate the infection.

Targeting Bacteria

Because this medication specifically targets the unique way bacteria build their cell walls, it does not affect human cells in the same way. It is important to note that cefepime is only effective against bacterial infections. It will not work for viral infections, such as the common cold or the flu.

Common Side Effects

Common side effects of cefepime are often mild and may include:

• Pain, redness, or swelling at the site of injection
• Nausea or vomiting
• Diarrhea
• Headache
• Mild skin rash or itching

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious symptoms:

• Allergic Reactions: Hives, skin rash, swelling of the face, lips, or throat, and difficulty breathing or swallowing.
• Neurological Problems: Confusion, hallucinations, seizures, or uncontrollable muscle twitching. These effects are more common in individuals with kidney disease.
• Severe Diarrhea: Watery or bloody stools and stomach cramps, which may be signs of a Clostridioides difficile (C. diff) infection. This can occur during treatment or several months after the last dose.
• Kidney or Liver Issues: Yellowing of the skin or eyes (jaundice), dark urine, or a significant change in the frequency or amount of urination.
• Blood Changes: Unusual bruising, bleeding, or signs of a new infection such as a persistent fever or sore throat.
• Oral or Vaginal Yeast Infection: White patches in the mouth or changes in vaginal discharge, especially with prolonged use.

Neurological Risks

Serious neurological side effects have been reported with the use of cefepime. These include encephalopathy (disturbed brain function), seizures, and myoclonus (involuntary muscle twitching). These risks are significantly higher for individuals with impaired kidney function who do not receive appropriate dosage adjustments. Healthcare providers typically monitor kidney function to determine the correct dose and may adjust the treatment if kidney function declines.

Allergic Reactions

Severe and occasionally fatal hypersensitivity reactions, including anaphylaxis, can occur. Cefepime is generally avoided in individuals with a known history of immediate hypersensitivity to cefepime, other cephalosporins, penicillins, or other beta-lactam antibiotics. If an allergic reaction occurs, the medication must be discontinued immediately.

Clostridioides difficile-Associated Diarrhea

Like many antibiotics, cefepime can alter the normal bacteria in the colon, leading to an overgrowth of Clostridioides difficile. This can cause diarrhea ranging in severity from mild to fatal inflammation of the colon. This condition may occur during treatment or several months after the medication has been stopped.

Other Precautions

• Drug Resistance: Using cefepime without a proven or strongly suspected bacterial infection increases the risk of developing drug-resistant bacteria.
• Blood Clotting: Some patients, particularly those with kidney or liver impairment or those who are malnourished, may experience a decrease in prothrombin activity, which affects blood clotting. Monitoring may be necessary for those at risk.
• Secondary Infections: Prolonged use may result in the overgrowth of non-susceptible organisms, such as fungi, which may require additional treatment.

Pregnancy

There is limited information available regarding the use of cefepime in pregnant women. While studies in animals have not shown evidence of harm to the developing fetus, animal research does not always predict how a human will respond. Because of the lack of adequate and well-controlled studies in humans, healthcare providers generally only prescribe cefepime during pregnancy if the potential benefits justify the potential risks.

Breastfeeding

Cefepime is excreted into human breast milk in very low concentrations. While the amount an infant would ingest is small, caution is advised when administering this medication to someone who is breastfeeding. Potential concerns for a nursing infant include:

• Changes in the infant's natural gut bacteria, which may cause diarrhea.
• The development of fungal infections, such as oral thrush.
• The risk of an allergic reaction if the infant is sensitive to antibiotics in the cephalosporin class.

It is important to discuss the risks and benefits of using cefepime while breastfeeding with a healthcare professional to determine the best course of action for both the parent and the infant.

Available Forms

Cefepime is provided in several injectable formats for use in clinical settings:

• Powder for Injection: This form consists of a sterile powder in a vial that a healthcare provider must mix with a liquid before administration.
• Premixed Intravenous Solution: This form is a ready-to-use liquid solution provided in infusion containers.
• Combination Powder: Cefepime is also available as a powder for injection in combination with other active ingredients, such as enmetazobactam.

Administration Methods

Depending on the specific product and the condition being treated, cefepime may be administered in the following ways:

• Intravenous infusion (into a vein)
• Intramuscular injection (into a large muscle)

FDA Approval and Indications

Cefepime is an injectable antibiotic approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe infections. Approved indications include pneumonia, urinary tract infections, skin and skin structure infections, and intra-abdominal infections. It is also indicated for the management of febrile neutropenia.

Safety Communications and Warnings

The FDA has issued safety alerts regarding the potential for serious neurological adverse events, such as seizures and encephalopathy, when using cefepime. These events have primarily occurred in patients with kidney dysfunction who were given doses exceeding the recommended levels for their level of renal function. The FDA requires that dosage be adjusted for patients with impaired kidney function to prevent these complications.

Recent Regulatory Developments

The FDA continues to monitor the safety profile of cefepime. Recently, the agency has also approved combination therapies involving cefepime, such as its use with enmetazobactam, specifically for treating complicated urinary tract infections in adults.

How Cefepime is Administered

Cefepime is given by injection into a vein (intravenously). It is usually administered as an infusion that takes approximately 30 minutes to complete. This medication may be given in a hospital or clinic setting, or you may be taught how to administer it at home.

Home Administration

If you are using cefepime at home, follow these guidelines for safe administration:

• Check the solution: Before using, look at the liquid for any particles or discoloration. Do not use the medication if it is cloudy, contains visible particles, or has changed color significantly.
• Mixing: Do not mix cefepime with other medications in the same IV bag or line unless your healthcare provider has specifically told you to do so.
• Timing: Use this medication at evenly spaced intervals as directed by your doctor.
• Complete the course: Continue using the medication for the full length of time prescribed, even if your symptoms disappear after a few days. Stopping the drug too early may allow the infection to return.

Storage and Disposal

Follow the specific storage instructions provided with your medication, as some forms may require refrigeration while others can be kept at room temperature for a limited time. Always dispose of used needles, syringes, and IV supplies in a puncture-resistant container.